BYND CANNASOFT ENTERPRISES overview

ASHKELON, Israel and VANCOUVER, British Columbia, Jan. 25, 2024 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today that its EZ-G project team has arrived in Shenzhen, China to sign agreements with two of the largest manufacturers in the province to begin production of the EZ-G device and EZ-G Capsules. BYND Cannasoft intends to start mass production of its EZ-G device and EZ-G capsules after the Chinese New Year...

ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today a significant milestone in its intellectual property strategy as its Zigi Carmel Initiatives & Investments LTD subsidiary filed a national phase application for Its EZ-G Device. A national phase application corresponding to inventive concept III of PCT/IL2022/050783 was filed on December 7, 2023, as a...

Israel's Finance Ministry has increased the Israel Innovation Authority's Fast-Track Fund up to US$100 Million i , Empowering its high-tech sector amid wartime challenges Israel-based BYND Cannasoft has submitted a research and development plan to develop CRM software combined with AI for the medical cannabis industry ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 16, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the...

ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”), announced today a new plan of work that focuses on its proprietary CRM platform in an effort to help meet the increased demand for medical cannabis in Israel. Recent regulatory reforms approved by the Israeli Ministry of Health i allows physicians to prescribe cannabis to patients as a first-line treatment...

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN , CSE: BYND ) (“ BYND ” or the “ Company ”) has released its financial results for the six-month period ended June 30, 2023. Full versions of BYND's unaudited consolidated interim financial statements and management discussion and analysis for the period can be found on www.sedar.com . Q2 2023 Financial Highlights: Revenue increased 21% to $251,047 in Q2 2023 from $207,653 in Q2...

ASHKELON, Israel and VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced that Yftah Ben Yaackov, Chief Executive Officer and Director, shared a comprehensive update on the Company's progress, highlighting significant recent milestones and unveiling promising prospects for the future. Since acquiring Zigi Carmel Initiatives & Investments LTD., BYND Cannasoft has been planning...

ASHKELON, Israel and VANCOUVER, British Columbia, July 31, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN ) (CSE: BYND ) (" BYND Cannasoft " or the " Company ") announced today Zigi Carmel Initiatives & Investments LTD, a wholly owned subsidiary of BYND Cannasoft, has filed a patent application for its AI based EZ-G device with the World Intellectual Property Office, also known as WIPO. The patent application listed as Publication Nu m ber WO/2023/13195 was published on...

ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN ) (CSE : BYND ) (" BYND Cannasoft " or the " Company ") today announced several milestones for the second half of 2023 on the development of its groundbreaking EZ-G Device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, could enhance therapeutic approaches for women's health issues by offering cutting-edge technology to cater to the...